Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

5(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 15 (100.0%)

Trials by Status

completed480%

withdrawn120%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_1

Study of BLZ-100 in Pediatric Subjects With CNS Tumors

NCT02462629

completedphase_1

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

NCT02496065

withdrawnphase_1

Clinical Trials (5)

Showing 5 of 5 trials

NCT02462629Phase 1

Study of BLZ-100 in Pediatric Subjects With CNS Tumors

Completed

NCT02496065Phase 1

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

Completed

NCT02464332Phase 1

Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery

Withdrawn

NCT02234297Phase 1

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

Completed

NCT02097875Phase 1

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5